Upcoming Events

Continuing Education Webinar: Purified Amniotic fluid is far more than a protective cushion; it is a complex molecular powerhouse rich in bioactive compounds. At its core, it contains a potent concentration of cytokines, growth factors, and extracellular vesicles (exosomes) that facilitate cellular communication and tissue repair. By harnessing Purified Amniotic Fluid, clinicians are tapping into a versatile therapeutic resource with a wide range of applications.  Join us for an exclusive session with one of the nation’s foremost experts as we explore the cutting edge of biologics. Delve into the molecular relevance and transformative clinical applications of purified amniotic fluid.   

​

Featuring Special Guest Robert Kellar.   Dr. Robert Kellar is a Professor at Northern Arizona University in the Center for Materials Interfaces in Research Applications (¡MIRA!), Biological Sciences, and Mechanical Engineering. Dr. Kellar received his Ph.D. from the University of Arizona in 2001 and has over 24 years of experience in the development and regulatory approval of medical devices, pharmaceuticals, and biologics, including cell-based products and regenerative medicine and tissue engineered technology. He serves as the CEO for Development Engineering Sciences, CEO for KMP Global, the Chief Development Officer for NEXT Life Sciences. Robert is the President and Chief Science Officer of Cellcura Sciences, and currently serves on the Board of Directors for Leonhardt Ventures, the Board of Directors for Protein Genomics, the Scientific Advisory Board for Aesthetics Biomedical, and the Advisory Board for the California Stock Exchange. 

​

To register for the webinar please click the following link.